Moreover, Rosenbaum et al. [24] reported a percentage of 18.2% of genomic HRD alterations (including BRCA1/2 genes) in uLMS, versus 10.0% in soft tissue sarcomas. This evidence concerns the gene BRCA1 and soft tissue sarcoma.